Future of cord blood for oncology uses (Q37607977)

21 August 2017

1 reference

title

Future of cord blood for oncology uses (English)

1 reference

21 August 2017

C G Brunstein

1

1 reference

21 August 2017

D J Weisdorf

series ordinal

2

1 reference

21 August 2017

language of work or name

English

0 references

publication date

5 October 2009

1 reference

Bone Marrow Transplantation

21 August 2017

published in

1 reference

21 August 2017

volume

44

1 reference

21 August 2017

issue

10

1 reference

21 August 2017

page(s)

699-707

1 reference

Paucity of HLA-identical unrelated donors for African-Americans with hematologic malignancies: the need for new donor options

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038/BMT.2009.286

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2009.286

Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow: results of a matched-pair analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2009.286

Busulfan/melphalan/antithymocyte globulin followed by unrelated donor cord blood transplantation for treatment of infant leukemia and leukemia in young children: the Cord Blood Transplantation study (COBLT) experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2009.286

Outcomes of unrelated cord blood transplants and allogeneic-related hematopoietic stem cell transplants in children with high-risk acute lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2009.286

Donor selection for unrelated cord blood transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2009.286

Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2009.286

Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2009.286

Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2009.286

Allogeneic hematopoietic stem cell transplantation in adult acute lymphocytic leukemia: impact of donor source on survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2009.286

Intra-BM injection to enhance engraftment after myeloablative umbilical cord blood transplantation with two partially HLA-matched units.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2009.286

Direct intrabone transplant of unrelated cord-blood cells in acute leukaemia: a phase I/II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2009.286

Cord blood transplants supported by co-infusion of mobilized hematopoietic stem cells from a third-party donor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2009.286

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2009.286

Dose-dependent effects of the Notch ligand Delta1 on ex vivo differentiation and in vivo marrow repopulating ability of cord blood cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2009.286

AMD3100 and CD26 modulate mobilization, engraftment, and survival of hematopoietic stem and progenitor cells mediated by the SDF-1/CXCL12-CXCR4 axis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2009.286

Mobilization studies in mice deficient in either C3 or C3a receptor (C3aR) reveal a novel role for complement in retention of hematopoietic stem/progenitor cells in bone marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2009.286

Transplantation studies in C3-deficient animals reveal a novel role of the third complement component (C3) in engraftment of bone marrow cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2009.286

Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2009.286

Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2009.286

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2009.286

Reduced-intensity conditioning followed by unrelated umbilical cord blood transplantation for advanced hematologic malignancies: rapid engraftment in bone marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2009.286

Successful engraftment after reduced-intensity umbilical cord blood transplantation for adult patients with advanced hematological diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2009.286

Reduced-intensity unrelated cord blood transplantation for patients with advanced malignant lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2009.286

High incidence of graft failure in unrelated cord blood transplantation using a reduced-intensity preparative regimen consisting of fludarabine and melphalan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2009.286

Promising progression-free survival for patients low and intermediate grade lymphoid malignancies after nonmyeloablative umbilical cord blood transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2009.286

Marked increased risk of Epstein-Barr virus-related complications with the addition of antithymocyte globulin to a nonmyeloablative conditioning prior to unrelated umbilical cord blood transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2009.286

Reduced-intensity allogeneic transplant in patients older than 55 years: unrelated umbilical cord blood is safe and effective for patients without a matched related donor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2009.286

Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2009.286

Myeloablative intravenous busulfan/fludarabine conditioning does not facilitate reliable engraftment of dual umbilical cord blood grafts in adult recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2009.286

Acute graft-versus-host disease after unrelated donor umbilical cord blood transplantation: analysis of risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2009.286

Reduced intensity allogeneic umbilical cord blood transplantation in children and adolescent recipients with malignant and non-malignant diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2009.286

Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2009.286

Transplants of Umbilical-Cord Blood or Bone Marrow from Unrelated Donors in Adults with Acute Leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2009.286

Analysis of Risk Factors for Outcomes After Unrelated Cord Blood Transplantation in Adults With Lymphoid Malignancies: A Study by the Eurocord-Netcord and Lymphoma Working Party of the European Group for Blood and Marrow Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2009.286

KIR-ligand incompatibility in the graft-versus-host direction improves outcomes after umbilical cord blood transplantation for acute leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2009.286

Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2009.286

7 January 2021

Allogeneic sibling umbilical-cord-blood transplantation in children with malignant and non-malignant disease

1 reference

https://api.crossref.org/works/10.1038/BMT.2009.286

7 January 2021

Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group

1 reference

https://api.crossref.org/works/10.1038/BMT.2009.286

7 January 2021

Outcomes among 562 recipients of placental-blood transplants from unrelated donors

1 reference

https://api.crossref.org/works/10.1038/BMT.2009.286

7 January 2021

Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study

1 reference

https://api.crossref.org/works/10.1038/BMT.2009.286

7 January 2021

Single-institute comparative analysis of unrelated bone marrow transplantation and cord blood transplantation for adult patients with hematologic malignancies

1 reference

https://api.crossref.org/works/10.1038/BMT.2009.286

7 January 2021

Comparative single-institute analysis of cord blood transplantation from unrelated donors with bone marrow or peripheral blood stem-cell transplants from related donors in adult patients with hematologic malignancies after myeloablative conditioning

1 reference

https://api.crossref.org/works/10.1038/BMT.2009.286

7 January 2021

Cord blood transplants: early recovery of neutrophils from co-transplanted sibling haploidentical progenitor cells and lack of engraftment of cultured cord blood cells, as ascertained by analysis of DNA polymorphisms

1 reference

https://api.crossref.org/works/10.1038/BMT.2009.286

7 January 2021

Stromal cell-derived factor-1/CXCL12 directly enhances survival/antiapoptosis of myeloid progenitor cells through CXCR4 and Gαi proteins and enhances engraftment of competitive, repopulating stem cells

1 reference

https://api.crossref.org/works/10.1038/BMT.2009.286

7 January 2021

Cleavage fragments of the third complement component (C3) enhance stromal derived factor-1 (SDF-1)-mediated platelet production during reactive postbleeding thrombocytosis.

1 reference

https://api.crossref.org/works/10.1038/BMT.2009.286

7 January 2021

Successful engraftment of mismatched unrelated cord blood transplantation following reduced intensity preparative regimen using fludarabine and busulfan

1 reference

https://api.crossref.org/works/10.1038/BMT.2009.286

7 January 2021

Disparate lymphoid chemokine expression in mice and men: no evidence of CCL21 synthesis by human high endothelial venules

1 reference

https://api.crossref.org/works/10.1038/BMT.2009.286

7 January 2021

Tacrolimus as prophylaxis for acute graft-versus-host disease in reduced intensity cord blood transplantation for adult patients with advanced hematologic diseases

1 reference

https://api.crossref.org/works/10.1038/BMT.2009.286

7 January 2021

Umbilical cord blood transplantation after reduced-intensity conditioning for elderly patients with hematologic diseases

1 reference

https://api.crossref.org/works/10.1038/BMT.2009.286

7 January 2021

Reduced-intensity umbilical cord blood transplant for older adult patients

1 reference

https://api.crossref.org/works/10.1038/BMT.2009.286

7 January 2021

Creation of a double chimera after the transplantation of umbilical-cord blood from two partially matched unrelated donors

1 reference

https://api.crossref.org/works/10.1038/BMT.2009.286

7 January 2021

Identifiers

DOI

10.1038/BMT.2009.286

1 reference

21 August 2017

1 reference